Ferro-Max C For higher iron absorption.
W NE
TM
Available from Symbion, Sigma and API.
Wed 16th Dec 2020
Use only as directed. Consult your healthcare professional if symptoms persist.
MBS access a game changer for QUM
TASMANIAN PHARMACY CONFERENCE 20 & 21 February 2021 Crowne Plaza Hotel Hobart The borders are open and Hobart in February is a fabulous place to be. Come on down and enjoy the opportunity to network with peers and be inspired by a mix of relevant and clinical content. Currently applying for CPD accreditation.
MEDICARE Benefits Schedule (MBS) reimbursements to support non-medical practitioner involvement in case conferencing would be a “game changer in improving safe and quality use of medicines (QUM)” the Pharmaceutical Society of Australia (PSA) believes. PSA National President, Associate Professor Chris Freeman, backed proposals in the MBS Review Taskforce’s final report, which was released earlier this week, to provide a rebate to encourage non-medical health professionals, including pharmacists, to take part in case conferences. “PSA has championed pharmacists’ access to collaborative care items on the MBS for a long period of time and this recommendation to the Federal Health Minister brings us one step closer to achieving this,” he said. “Creating MBS items for nonmedical health practitioners to
align with the equivalent GP items will foster better collaboration and enhanced safe and quality use of medicine outcomes for patients. “This recommendation, if implemented by Government, means pharmacists will be one of the eligible groups to be remunerated for participation in interdisciplinary case conferences. “Across community pharmacies, aged care, and in general practice the change to case conference reimbursement in addition to the recent introduction of the follow
up medication reviews will be a game changer in improving the safe and quality use of medicines.” Freeman added that the expansion of MBS items would support efforts to strengthen, modernise and protect the Australian health system, ensuring it is able to meet the needs of patients into the future. “We look forward to working with the Federal Government to progress relevant recommendations to implementation,” he said.
Sunburn?
DermAid!
For temporary relief of minor skin irritation, itching, rashes† and sunburn
Today’s issue of PD Pharmacy Daily today features two pages of news.
FIND OUT MORE Over 20 years’ experience
✓
✓ “Sue Raven’s genuine, thorough, and superbly effective approach to pharmacy brokering We have tried different brokers with no luck of finalising a deal but thanks to Sue she was able to find the appropriate purchaser” Bob (TAS)
Pharmacy Daily
✓
✓
LET US HELP YOU!
Looking at selling, we can help you as we have buyers who have already sourced finance and are keen to buy now (All States) as we have affiliates If you are buyer, we can help you as we act as buyer’s agent for you Thinking of selling and been wondering what your pharmacy might be worth on the market we can help you; we can do and assessment and give you an indication what it would be worth on the market Now also offering Consultancy. Click her to find out more M: 0407 759 736|E: sue.raven@srpbs.com.au W: www. srpbs.com.au
e info@pharmacydaily.com.au
.
P Suitable for use on children aged 2 and above* P Free from colour, fragrance and alcohol P Contains a moisturiser to help soothe dry skin P Dissolved hydrocortisone to work fast *Consult a doctor before use on children under 2 years of age.
.
†
Due to corticosteroid responsive skin conditions
DermAid 1.0% w/w: ASK YOUR PHARMACIST – THEY MUST DECIDE IF THIS PRODUCT IS RIGHT FOR YOU. Always read the label. Follow the directions for use. If symptoms persist, worsen or change unexpectedly talk to your health professional. EGO PHARMACEUTICALS PTY LTD. 21–31 Malcolm Road, Braeside 3195 Australia. ‘Ego’ and ‘DermAid’ are trademarks of Ego Pharmaceuticals Pty Ltd. ©2019 Ego. ask@egopharm.com www.egopharm.com Prepared December 2019
t 1300 799 220
w www.pharmacydaily.com.au
page 1